LGND - Ligand Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. Estimate0.610.763.253.81
Low Estimate0.540.733.23.63
High Estimate0.650.793.34
Year Ago EPS1.321.77.153.25
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. Estimate22.36M27.55M119.71M126.17M
Low Estimate21.13M26.49M117.7M122.27M
High Estimate24.52M28.58M125M129.4M
Year Ago SalesN/A59.59M251.45M119.71M
Sales Growth (year/est)N/A-53.80%-52.40%5.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.1.031.221.020.55
EPS Actual1.321.71.160.68
Difference0.290.480.140.13
Surprise %28.20%39.30%13.70%23.60%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate0.610.763.253.81
7 Days Ago0.640.813.253.81
30 Days Ago0.650.793.223.71
60 Days Ago0.650.793.223.71
90 Days Ago0.690.823.263.77
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/AN/A
Growth EstimatesLGNDIndustrySectorS&P 500
Current Qtr.-53.80%N/AN/A-0.02
Next Qtr.-55.30%N/AN/A0.07
Current Year-54.50%N/AN/A-0.02
Next Year17.20%N/AN/A0.14
Next 5 Years (per annum)11.50%N/AN/A0.07
Past 5 Years (per annum)33.96%N/AN/AN/A